Search News

News Results

There are 686,426 News Results

Sep 23, 2025

ARIANA GRANDE DEBUTS TWO WICKED-INSPIRED FRAGRANCES AHEAD OF THE RELEASE OF WICKED: FOR GOOD, IN PARTNERSHIP WITH UNIVERSAL PICTURES

NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Ahead of the cinematic conclusion to last year's global cultural sensation

Sep 24, 2025

AI Code Generation Tool Market Size to Hit USD 26.2 Billion by 2030, Growing at 27.1% CAGR | Market Forecast 2024-2031 - Valuates Reports

BANGALORE, India, Sept. 24, 2025 /PRNewswire/ --

Sep 25, 2025

CONCORSO ITALIANO 40TH ANNIVERSARY DELIVERS A CELEBRATION TO REMEMBER

"2025 Event Date Announced Coming Off Spectacular Comeback"

Jun 2, 2017

Further Study of Combination of Eisai's Lenvatinib and Merck's Pembrolizumab in Previously Treated Patients with Metastatic Endometrial Cancer Supported by Interim Analysis of Ongoing Phase 1b/2 Trial

WOODCLIFF LAKE, N.J., June 3, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the first evaluable cohort of Study 111, a Phase 1b/2 study investigating lenvatinib (marketed as...

Jun 6, 2017

Equity Strategies Snag All Top 20 Spots on eVestment Global Screening List; UK Users Globally Focused

ATLANTA, June 7, 2017 /PRNewswire/ -- All 20 of the most popular investment products viewed in May by institutional investment professionals using eVestment were equity focused in May 2017, according...

Jul 6, 2017

Deadline to Acquire BeamReach Solar Intellectual Property Extended

NEW YORK, July 7, 2017 /PRNewswire/ -- OB Realty, LLC, an affiliate of Opus Bank, the former secured lender to BeamReach Solar, is pleased to announce that since April, it...

Jul 9, 2017

Global Next Generation Sequencers - Clinical Diagnostics

NEW YORK, July 10, 2017 /PRNewswire/ --

Jul 9, 2017

Global Acute Myeloid Leukemia (AML) Therapeutics - Pharmaceuticals

NEW YORK, July 10, 2017 /PRNewswire/ --

Jul 24, 2017

Eisai Submits Supplemental New Drug Application to FDA for Lenvatinib in First-Line Hepatocellular Carcinoma

WOODCLIFF LAKE, N.J., July 25, 2017 /PRNewswire/ -- Eisai Inc. today announced it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the...

Sep 9, 2017

Combination of Lenvatinib and Pembrolizumab Results in Notable Response Rates for Patients with Advanced Renal Cell Carcinoma Based on Interim Analysis of Ongoing Phase 1b/2 Trial

WOODCLIFF LAKE, N.J., Sept. 10, 2017 /PRNewswire/ -- Eisai Inc. today announced interim results from the advanced renal cell carcinoma (RCC) cohort of Study 111, a Phase 1b/2 study investigating...

Stories of the day

Sep 25, 2025
Boeing to Relocate F/A-18 Service Life Modification Work to Support St. Louis...
Boeing is considering multiple sites to transfer the work to with case studies starting at the San Antonio and Jacksonville sites.
Sep 25, 2025
Integrated Battle Command System Achieves Major Milestone with First Successful...
During the event conducted in Poland, IBCS successfully engaged and intercepted surrogate air-breathing targets
Sep 25, 2025
RTXs Raytheon and Avio USA expand collaboration to accelerate Mk 104 rocket...
Avio USA and Raytheon have executed a purchase order for funding of up to $26 million for continued engineering work on the Mk 104 dual-thrust rocket motor to support Raytheon’s Standard Missile franchise.
Sep 26, 2025
Latvia orders Rheinmetall ammunition factory – Group expands global ammunition...
The facility shall be operated by a joint venture between Rheinmetall Waffe Munition GmbH (51%) and the Latvian State Defence Corporation, LLC of Latvia (49%).